Delphine Diagnostics
Delphine Diagnostics is a New Jersey–based medical diagnostics company focused on rapid molecular assays and AI/ML-driven clinical decision support for infectious diseases, with an emphasis on sepsis. The company develops real-time PCR–based diagnostic kits, clinician-facing machine‑learning tools, health-data analytics capacity, and pursues manufacturing, regulatory clearance, and grant-funded R&D to support deployment in clinical and laboratory settings.
Industries
Nr. of Employees
small (1-50)
Delphine Diagnostics
Newark, Delaware, United States, North America
Products
Sepsis diagnostic panel (molecular test kit)
A molecular diagnostic panel under development intended to detect pathogen and host markers for sepsis to support rapid, personalized treatment decisions.
Sepsis prediction machine‑learning tool
A web‑accessible machine‑learning tool for sepsis risk prediction intended to support clinician decision making; reported plans for ensemble model verification for point‑of‑care use.
AI/ML healthcare platform
Platform services to host and deliver machine learning models, analytics, and decision support for infectious disease diagnostics.
Acinetobacter baumannii real-time PCR Assay
A PathoSeek research-use real-time PCR assay for A. baumannii detection in environmental monitoring and infection-control research.
Escherichia coli real-time PCR Assay
A PathoSeek research-use real-time PCR assay for detecting E. coli DNA in research and monitoring workflows. Runs using TaqMan hydrolysis-probe chemistry.
Bacterial Pathogen Detection Panel
A real-time PCR panel for rapid detection of three widely studied bacterial pathogens associated with healthcare-associated infections, environmental contamination, and antimicrobial-resistance research.
Sepsis diagnostic panel (molecular test kit)
A molecular diagnostic panel under development intended to detect pathogen and host markers for sepsis to support rapid, personalized treatment decisions.
Sepsis prediction machine‑learning tool
A web‑accessible machine‑learning tool for sepsis risk prediction intended to support clinician decision making; reported plans for ensemble model verification for point‑of‑care use.
AI/ML healthcare platform
Platform services to host and deliver machine learning models, analytics, and decision support for infectious disease diagnostics.
Acinetobacter baumannii real-time PCR Assay
A PathoSeek research-use real-time PCR assay for A. baumannii detection in environmental monitoring and infection-control research.
Escherichia coli real-time PCR Assay
A PathoSeek research-use real-time PCR assay for detecting E. coli DNA in research and monitoring workflows. Runs using TaqMan hydrolysis-probe chemistry.
Bacterial Pathogen Detection Panel
A real-time PCR panel for rapid detection of three widely studied bacterial pathogens associated with healthcare-associated infections, environmental contamination, and antimicrobial-resistance research.
Services
Onboarding, technical support, and app deployment services to integrate diagnostic kits and ML decision‑support tools into clinical workflows.
Development and provision of machine learning models and analytics platforms to support sepsis prediction and health data analysis.
Planned establishment of a logistics network connecting certified laboratories to a central facility to provide molecular and pathological testing services across regions.
Onboarding, technical support, and app deployment services to integrate diagnostic kits and ML decision‑support tools into clinical workflows.
Development and provision of machine learning models and analytics platforms to support sepsis prediction and health data analysis.
Planned establishment of a logistics network connecting certified laboratories to a central facility to provide molecular and pathological testing services across regions.
Expertise Areas
- Sepsis diagnostics
- Molecular diagnostics
- AI‑driven diagnostics and clinical decision support
- Assay development and validation
Key Technologies
- Real‑time PCR (qPCR)
- Nucleic acid amplification
- Molecular assay development
- AI/ML ensemble models
News & Updates
Regulatory notification of intent to distribute a molecular COVID‑19 test was accepted by the U.S. FDA Center for Devices and Radiological Health under COVID‑19 testing policy.
Recipient of the New Jersey Commission on Science Innovation and Technology Maternal and Infant Health R&D Award recognizing development of faster diagnostic solutions for pregnant women and infants.
A company scientist received a state innovation fellowship grant to support development of the company's sepsis diagnostic assay.
Regulatory notification of intent to distribute a molecular COVID‑19 test was accepted by the U.S. FDA Center for Devices and Radiological Health under COVID‑19 testing policy.
Recipient of the New Jersey Commission on Science Innovation and Technology Maternal and Infant Health R&D Award recognizing development of faster diagnostic solutions for pregnant women and infants.
A company scientist received a state innovation fellowship grant to support development of the company's sepsis diagnostic assay.